Asset Impairment, Exit, and Restructuring Costs	9 Months Ended
	Sep. 30, 2023
Restructuring, Settlement and Impairment Provisions [Abstract]
Asset Impairment, Exit, and Restructuring Costs	Asset Impairment, Exit, and Restructuring CostsAsset impairment, exit, and restructuring costs in the three and nine months ended September 30, 2023 consisted of impairments related to certain long-lived assets and intangibles of $74 million and $120 million, respectively, and restructuring charges of $3 million and $21 million, respectively, presented as specified items within segment operating profit, and restructuring charges in Corporate of $2 million and $5 million, respectively. Intangibles impairments in the three and nine months ended September 30, 2023 of $37 million and $62 million, respectively, was primarily related to discontinued animal nutrition trademarks in the Nutrition segment.Asset impairment, exit, and restructuring costs in the three and nine months ended September 30, 2022 consisted of impairments related to certain long-lived assets of $16 million and $20 million, respectively, and restructuring charges of $12 million and $12 million, respectively, presented as specified items within segment operating profit, and a restructuring adjustment in Corporate of $2 million in the nine months ended September 30, 2022.